Peptide-functionalized biomaterials are emerging as a transformative approach in the field of regenerative dentistry, particularly for dentin regeneration. By leveraging the specificity and bioactivity of peptides, these advanced materials aim to mimic the natural extracellular matrix, enhance cellular responses, and direct tissue regeneration in a targeted manner. This review comprehensively discusses the epidemiology of dentin defects, underlying pathophysiology, risk factors, clinical features, diagnostic strategies, current and emerging therapeutic approaches, and evidence-based guideline recommendations with a focus on peptide-functionalized biomaterials. The clinical translation and future prospects of these innovative technologies are also critically evaluated for their potential to redefine patient care in restorative dentistry.
Dentin, a vital component of the tooth structure, plays a crucial role in maintaining tooth integrity, function, and protection of the dental pulp. Damage to dentin as a result of caries, trauma, or restorative procedures presents a significant clinical challenge, often leading to pain, sensitivity, and increased risk of tooth loss. Conventional restorative materials, while effective in the short term, frequently lack the capacity to regenerate native dentin tissue. Recent advances in tissue engineering have introduced peptide-functionalized biomaterials as promising candidates to promote true biological repair and regeneration of dentin. This article explores the scientific basis, clinical relevance, and translational potential of peptide-functionalized biomaterials in dentin regeneration.
Dentin defects are highly prevalent worldwide, primarily due to dental caries, which remains the most common chronic disease globally. According to recent epidemiological surveys, over 2.5 billion people are affected by dental caries, with a considerable proportion progressing to dentin involvement. Additionally, non-carious cervical lesions, traumatic injuries, and restorative treatments contribute to the global burden of dentin loss. The consequences of untreated dentin defects include pulpitis, tooth fracture, and eventual tooth loss, imposing significant socioeconomic and healthcare costs. Addressing the repair and regeneration of dentin thus represents a major unmet need in dental practice.
Dentin is a mineralized tissue composed of a collagenous matrix impregnated with hydroxyapatite crystals. Injury to dentin, whether through carious demineralization, abrasion, or trauma, disrupts the structural integrity and exposes the dental pulp to microbial invasion and inflammation. The natural reparative response involves the activation of odontoblasts or odontoblast-like cells to deposit tertiary dentin. However, this endogenous capacity is limited and often insufficient for complete regeneration, particularly in extensive defects. Peptide-functionalized biomaterials are designed to provide bioactive cues that guide cell recruitment, differentiation, and matrix deposition, thereby recapitulating the physiological processes of dentinogenesis.
Multiple risk factors contribute to the development and progression of dentin defects. The primary risk factor is dental caries, driven by poor oral hygiene, high sugar intake, and inadequate fluoride exposure. Other risk factors include mechanical abrasion from aggressive tooth brushing, erosive dietary habits, bruxism, dental trauma, and iatrogenic damage during restorative procedures. Genetic predispositions, systemic diseases affecting mineral metabolism, and age-related changes in dentin structure also play contributory roles. Identifying and mitigating these risk factors is essential for the prevention and long-term success of regenerative therapies.
Clinically, dentin defects manifest as tooth sensitivity, pain on thermal or osmotic stimuli, and visible cavitation or loss of tooth substance. Advanced lesions may present with discoloration, pulp exposure, and signs of pulpitis or periapical pathology. Accurate clinical assessment, including inspection, palpation, and functional testing, is vital for diagnosis and treatment planning. The extent, depth, and location of the dentin defect, as well as the vitality of the pulp, determine the choice of therapeutic intervention.
Diagnosis of dentin defects involves a combination of clinical examination and adjunctive diagnostic tools. Radiographic imaging, particularly periapical and bitewing radiographs, provides valuable information regarding the depth and extent of the lesion. Advanced imaging modalities such as cone-beam computed tomography (CBCT) offer three-dimensional assessment of complex cases. Pulp vitality tests, laser Doppler flowmetry, and optical coherence tomography may further aid in evaluating pulp status and planning regenerative procedures. Accurate diagnosis is critical to ensure appropriate case selection for peptide-functionalized biomaterial-based therapies.
Traditional management of dentin defects relies on restorative materials such as composites, glass ionomer cements, and amalgam, which primarily restore function but do not regenerate lost tissue. In cases of deep lesions, indirect or direct pulp capping with calcium hydroxide or mineral trioxide aggregate (MTA) is employed to preserve pulp vitality and stimulate tertiary dentin formation. However, these conventional approaches have limitations in terms of biological integration, durability, and regenerative potential. Peptide-functionalized biomaterials, by contrast, are engineered to provide instructive signals that actively promote the recruitment and differentiation of progenitor cells, enhance extracellular matrix synthesis, and facilitate the deposition of mineralized tissue. These bioactive scaffolds may be delivered as injectable hydrogels, sponges, or coatings, and are often combined with growth factors or stem cells for synergistic effects.
The last decade has witnessed significant progress in the design and application of peptide-functionalized biomaterials for dentin regeneration. Self-assembling peptide hydrogels, such as those incorporating the RGD (arginine-glycine-aspartic acid) motif or dentin matrix protein-derived sequences, have demonstrated the ability to support odontogenic differentiation and mineralization in vitro and in vivo. Peptides derived from amelogenin, bone morphogenetic protein (BMP), and other extracellular matrix proteins have been conjugated to biomaterial surfaces to enhance cell adhesion and direct lineage-specific differentiation. Recent studies have also explored the use of peptide amphiphiles, which self-assemble into nanofibrous structures that closely mimic the native dentin matrix. These emerging therapies are supported by preclinical and early clinical data showing improved tissue integration, reduced inflammation, and enhanced functional restoration compared to conventional materials.
While formal clinical guidelines specifically addressing peptide-functionalized biomaterials for dentin regeneration are still evolving, several consensus statements and expert recommendations advocate for their consideration in well-selected cases. The European Society of Endodontology and the American Association of Endodontists emphasize the importance of preserving pulp vitality and promoting biological repair. The integration of bioactive and peptide-functionalized materials is recognized as a promising strategy, particularly in cases where conventional therapies are inadequate or where regenerative outcomes are desired. Ongoing clinical trials and longitudinal studies are expected to refine these recommendations and inform best practices for the adoption of peptide-functionalized biomaterials in clinical dentistry.
Peptide-functionalized biomaterials represent a paradigm shift in the management of dentin defects, offering the potential for true biological regeneration and restoration of tooth function. By harnessing the specificity of peptides and the versatility of advanced biomaterials, these technologies address the limitations of conventional restorative materials and align with the goals of minimally invasive, patient-centered care. Continued research, clinical validation, and guideline development will be essential to fully realize the promise of peptide-functionalized biomaterials in dentin regeneration and to establish their role in the future of restorative dentistry.
1.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
Low Income, Education Tied to Depression in Older Adults
5.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
1.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
2.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
3.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation